Protein posttranslational modifications: roles in aging and age-related disease
Although the FDA has yet to approve BPC-157 for humans, studies show that it has beneficial effects on stroke, schizophrenia, and spinal cord injury [1]
This also led its drug manufacturer, Novo Nordisk, to get a higher dose of the active ingredient semaglutide FDA-approved for weight management under the brand name Wegovy
#FunctionalMedicine #DetoxSupport #HolisticHealth #CleanLiving #HealthyHabits #IntegrativeMedicine #HealthySwaps To view or add a comment, sign in These are 10 things I actually use as a functional medicine practitioner and chiropractic kinesiologist
Food Chem Toxicol 153:112266 Akay H, Akay T, Secilmis S, Kocak Z, Donderici O (2006) Hepatotoxicity after low-dose cyclophosphamide therapy